Last reviewed · How we verify
Posaconazole powder for oral suspension — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Posaconazole powder for oral suspension (Posaconazole powder for oral suspension) — Merck Sharp & Dohme LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Posaconazole powder for oral suspension TARGET | Posaconazole powder for oral suspension | Merck Sharp & Dohme LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Posaconazole powder for oral suspension CI watch — RSS
- Posaconazole powder for oral suspension CI watch — Atom
- Posaconazole powder for oral suspension CI watch — JSON
- Posaconazole powder for oral suspension alone — RSS
Cite this brief
Drug Landscape (2026). Posaconazole powder for oral suspension — Competitive Intelligence Brief. https://druglandscape.com/ci/posaconazole-powder-for-oral-suspension. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab